PBYI
Puma Biotechnology Inc
NASDAQ · Biotechnology
$6.94
+0.15 (+2.21%)
Open$6.88
Previous Close$6.79
Day High$7.05
Day Low$6.85
52W High$5.05
52W Low$3.29
Volume—
Avg Volume607.6K
Market Cap349.71M
P/E Ratio36.38
EPS$0.11
SectorBiotechnology
Analyst Ratings
Strong Sell
7 analysts
Price Target
-21.5% upside
Current
$6.94
$6.94
Target
$5.45
$5.45
$2.99
$5.45 avg
$6.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 46.64M | 42.11M | 46.96M |
| Net Income | 10.01M | 7.89M | 10.24M |
| Profit Margin | 21.5% | 18.7% | 21.8% |
| EBITDA | 15.43M | 13.15M | 15.14M |
| Free Cash Flow | 4.56M | 4.76M | 6.11M |
| Rev Growth | +7.5% | +7.6% | -6.0% |
| Debt/Equity | 0.44 | 0.46 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |